MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Subthalamic nucleus(SIN)"

  • 2016 International Congress

    Increasing placebo response in Parkinson’s disease through apomorphine pre-conditioning

    E. Frisaldi, E. Carlino, L. Giudetti, A. Pampallona, M. Zibetti, M. Lanotte, L. Lopiano, F. Benedetti (Turin, Italy)

    Objective: To see whether a placebo response requires pharmacological pre-conditioning with apomorphine. Background: Placebos have been found to affect the patient's brain in a number…
  • 2016 International Congress

    A dopamine-dependent activity of the STN in the control of balance in Parkinson’s disease

    G. Arnulfo, N.G. Pozzi, C. Palmisano, A. Canessa, J. Brumberg, C.A. Frigo, G. Pezzoli, F. Steigerwald, J. Volkmann, I.U. Isaias (Würzburg, Germany)

    Objective: To investigate the activity of the subthalamic nucleus (STN), and its relation to nigro-striatal dopaminergic denervation, in control of balance in Parkinson's disease (PD).…
  • 2016 International Congress

    Reduction in battery longevity for each subsequent implantable pulse generator (IPG) in patients with Parkinson’s disease (PD) treated with bilateral subthalamic nucleus deep brain stimulation (STN-DBS) may be due to both programming changes and IPG model – a case series

    S.D. Israeli-Korn, S. Tessler, G. Yahalom, S. Benizri, O.S. Cohen, C. Shabat, H. Strauss, N. Warmann-Alaluf, E. Stein, Z. Zibly, R. Spiegelman, S. Hassin, S. Hassin (Ramat Gan, Israel)

    Objective: To determine whether the decrease in longevity following IPG replacement is due to programming changes and whether there is an effect of IPG model.…
  • 2016 International Congress

    Modulation of local field potentials during gait in the STN of patients with Parkinson’s disease

    F. Hell, J.H. Mehrkens, A. Plate, K. Bötzel (München, Germany)

    Objective: PD patients with implanted DBS electrodes allow for the investigation of basal ganglia activity during gait. Background: Whereas the overall spectral content of local…
  • 2016 International Congress

    Cortical and subcortical contribution in the production of reaching movements in Parkinson’s disease

    A. Canessa, N.G. Pozzi, G. Arnulfo, J. Brumberg, F. Steigerwald, M.F. Ghilardi, J. Volkmann, I.U. Isaias (Wuerzburg, Germany)

    Objective: To investigate the interplay between subthalamic nucleus (STN) activity and striatal dopamine deficiency in the production of arm movements in subjects with Parkinson's disease…
  • 2016 International Congress

    Suggested protocol for electroconvulsive therapy for depression in a Parkinson’s disease patient with a deep brain stimulator: A case report

    K. Dashtipour, M. Pereau, D. Trenkle, C. Osorio, K. Stoletniy (Loma Linda, CA, USA)

    Objective: To report an evidence for safety of ECT in patients with DBS in place. Background: We report a case of bilateral electroconvulsive therapy (ECT)…
  • 2016 International Congress

    Influence of different spike sorting algorithms on the detection of single unit spiking activity in the subthalamic nucleus of patients with Parkinson’s disease

    J. Sukiban, R. Pauli, T.A. Dembek, I. Weber, F. Jung, N. Voges, M. Denker, S. Gruen, L. Timmermann (Cologne, Germany)

    Objective: To determine the most suitable spike sorting algorithm for intraoperatively recorded extracellular currents in the subthalamic nucleus (STN) of patients with Parkinson's disease (PD).…
  • 2016 International Congress

    Effects of subthalamic deep brain stimulation in motor and nonmotor function in Parkinson’s disease patients with parkin mutation

    L.M. Oliveira, R.G. Cury, H.F. Chien, J.G. Santos, M.G. Ghilardi, R.B. Machado, E.T. Fonoff, B.R. Egberto (São Paulo, Brazil)

    Objective: The aim of our study was to evaluate prospectively the changes in motor, nonmotor symptoms (NMS) and quality of life produced by subthalamic deep…
  • 2016 International Congress

    Clinical outcome of subthalamic deep brain stimulation in Parkinson’s disease – The Helsinki experience

    M. Koivu, A. Huotarinen, F. Scheperjans, R. Kivisaari, E. Pekkonen (Helsinki, Finland)

    Objective: To evaluate the efficacy and adverse effects of subthalamic deep brain stimulation (STN-DBS) in patients with advanced Parkinson's disease (PD) and the possible correlation…
  • 2016 International Congress

    A prospective study of patients’ expectations in subthalamic nucleus deep brain stimulation for Parkinson’s disease

    N.R. Mundil, H.Y. Ling, H. Hasegawa, M. Samuel, K. Ashkan (London, United Kingdom)

    Objective: To prospectively assess the long-term outcome of subthalamic nucleus (STN) deep brain stimulation (DBS) and the relationship with patients' expectations and satisfaction. Background: Subthalamic…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley